Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,485 | 24,074 | 43,640 | 33,971 | 25,668 |
| Marketable Securities | 144,548 | 127,601 | 38,360 | 65,151 | 30,034 |
| Receivables | N/A | N/A | 1,083 | 3,225 | 5,043 |
| TOTAL | $216,601 | $154,577 | $88,278 | $104,617 | $66,648 |
| Non-Current Assets | |||||
| PPE Net | 6,178 | 2,811 | 4,120 | 5,029 | 2,438 |
| Investments And Advances | 0 | 17,464 | 0 | 0 | 0 |
| Intangibles | 197,797 | 11,613 | 11,613 | 0 | 0 |
| Other Non-Current Assets | 487,808 | 23,502 | 23,552 | 442 | 709 |
| TOTAL | $691,783 | $55,390 | $39,285 | $5,471 | $3,147 |
| Total Assets | $908,384 | $209,967 | $127,563 | $110,088 | $69,795 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,840 | 299 | 398 | 1,044 |
| Accounts payable and accrued liabilities | 73,616 | 16,345 | 10,162 | 8,845 | 9,708 |
| TOTAL | $73,616 | $20,185 | $10,461 | $9,243 | $19,256 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 10,510 | 14,174 | 299 | 0 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 8,504 |
| Other Non-Current Liabilities | 274,959 | 11,288 | 11,314 | 908 | 1,948 |
| TOTAL | $486,934 | $67,604 | $71,351 | $31,625 | $20,947 |
| Total Liabilities | $560,550 | $87,789 | $81,812 | $40,868 | $40,203 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,211 | 95,624 | 62,263 | 49,632 | 34,823 |
| Common Shares | 1,306 | 1,015 | 679 | 556 | 407 |
| Retained earnings | -579,566 | -447,448 | -378,522 | -318,889 | -270,104 |
| Other shareholders' equity | 8,640 | -132 | 1 | 14 | 4 |
| TOTAL | $347,834 | $122,178 | $45,751 | $69,220 | $29,592 |
| Total Liabilities And Equity | $908,384 | $209,967 | $127,563 | $110,088 | $69,795 |